Search Results

You are looking at 31 - 40 of 378 items for :

  • "early detection" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

PSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choice

Timothy J. Wilt and Philipp Dahm

is common, potentially deadly, and costly. 1 In the absence of PSA testing, there are no effective early detection options. Treatment for disease that has spread beyond the prostate does not provide cure. Therefore, public and health professional

Full access

Update on PSA Testing

Mark L. Gonzalgo and H. Ballentine Carter

1998 ; 160 : 2407 – 2411 . 17. Catalona WJ Richie JP deKernion JB . Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic

Full access

Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

Douglas E. Wood, Ella A. Kazerooni, Scott L. Baum, George A. Eapen, David S. Ettinger, Lifang Hou, David M. Jackman, Donald Klippenstein, Rohit Kumar, Rudy P. Lackner, Lorriana E. Leard, Inga T. Lennes, Ann N.C. Leung, Samir S. Makani, Pierre P. Massion, Peter Mazzone, Robert E. Merritt, Bryan F. Meyers, David E. Midthun, Sudhakar Pipavath, Christie Pratt, Chakravarthy Reddy, Mary E. Reid, Arnold J. Rotter, Peter B. Sachs, Matthew B. Schabath, Mark L. Schiebler, Betty C. Tong, William D. Travis, Benjamin Wei, Stephen C. Yang, Kristina M. Gregory, and Miranda Hughes

screening will lead to earlier detection of lung cancer—before patients have symptoms and when treatment is more likely to be effective—and will decrease mortality. 11 Data support using low-dose computed tomography (LDCT) of the chest to screen select

Full access

Barrett's Esophagus and Its Progression to Adenocarcinoma

Carlo C. Maley and Anil K. Rustgi

Barrett's esophagus: endoscopist and pathologist practices . Am J Gastroenterol 2001 ; 96 : 876 – 881 . 40. Pepe MS Etzioni R Feng Z . Phases of biomarker development for early detection of cancer . J Natl Cancer Inst 2001 ; 93 : 1054

Full access

Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

Dawn Provenzale, Samir Gupta, Dennis J. Ahnen, Travis Bray, Jamie A. Cannon, Gregory Cooper, Donald S. David, Dayna S. Early, Deborah Erwin, James M. Ford, Francis M. Giardiello, William Grady, Amy L. Halverson, Stanley R. Hamilton, Heather Hampel, Mohammad K. Ismail, Jason B. Klapman, David W. Larson, Audrey J. Lazenby, Patrick M. Lynch, Robert J. Mayer, Reid M. Ness, Scott E. Regenbogen, Niloy Jewel Samadder, Moshe Shike, Gideon Steinbach, David Weinberg, Mary Dwyer, and Susan Darlow

syndrome, surveillance (particularly for first or metachronous CRC) offers an opportunity for early detection and perhaps even prevention of cancer among mutation carriers. Further, cancer site-specific evaluation and heightened attention to symptoms is

Full access

Strategies for Colon Cancer Screening With Considerations of Cost and Access to Care

Randall W. Burt

Screening also has also been shown to come at an acceptable cost to society. 4 – 7 Colon cancer mortality has decreased in recent years, at least in part due to screening and early detection. 8 Just as important, the incidence of colon cancer has been

Full access

Should Resource Constraints Guide Global Guidelines?

Benjamin O. Anderson

limited-resource countries: early detection and access to care . Breast J 2006 ; 12 [ Suppl 1 ]: S16 – 26 . 11. Shyyan R Masood S Badwe RA . Breast cancer in limited-resource countries: diagnosis and pathology . Breast J 2006 ; 12 [ Suppl

Full access

NCCN Policy Summit: Cancer Care in the Workplace: Building a 21st Century Workplace for Patients, Survivors, and Caretakers

Victoria Hood, Lindsey Bandini, Taneal Carter, Alyssa Schatz, John Sweetenham, Warren Smedley, Joanna Fawzy Morales, Rebecca V. Nellis, Randy A. Jones, Lynn Zonakis, and Robert W. Carlson

Innovations in cancer treatment, advancements in early detection, and expanded healthcare access have significantly improved both survival rates for patients with cancer and quality of life for survivors. 1 National Cancer Institute projections

Full access

Sexual and Gender Minority Issues Across NCCN Guidelines: Results From a National Survey

Janella Hudson, Matthew B. Schabath, Julian Sanchez, Steven Sutton, Vani N. Simmons, Susan T. Vadaparampil, Peter A. Kanetsky, and Gwendolyn P. Quinn

' SOGI. 9 The NCCN multidisciplinary expert panels lead the nation in establishing clinical practice guidelines addressing cancer prevention, early detection, and treatment of cancer sites and populations. 10 Given the emerging body of research

Full access

Laboratory Selection in Germline Genetic Testing: Laboratory Science Matters

Suzanne M. Mahon

in the laboratory with the capability of detection, and unfortunately tested positive as well. The genetics professional provided recommendations for prevention and early detection for both the patient and her daughter. 3 Because this was known to be